img

Global Monoclonal Antibodies Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Monoclonal Antibodies Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins.
The global Monoclonal Antibodies market size was US$ 105790 million in 2024 and is forecast to a readjusted size of US$ 144360 million by 2034 with a CAGR of 4.5% during the forecast period 2024-2034.
This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodies are produced by using hybridoma technology. In hybridoma technology, the antibodies are obtained by fusion of human spleen cells and human myeloma. The characteristics of monoclonal antibodies which affect their efficacy are antigen specificity, overall structure and the affinity of the antibody for the target antigen or cells.
In terms of sales (consumption) side, this report focuses on the sales of Monoclonal Antibodies by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2034.
The global Monoclonal Antibodies market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Monoclonal Antibodies market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Biocon
Celltrion
Dr. Reddy's Laboratories
Hospira
3SBio
Accord Healthcare
AET Biotech
Allergan
Amega Biotech
By Type
Erythropoietin (EPO)
Human Growth Hormone (HGH)
Granulocyte- Colony Stimulating Factor (G-CSF)
Monoclonal Antibody (mAb)
Insulin
Interferon (IFN)
Others
By Application
Anti-Cancer
Anti-Inflammatory/Autoimmune
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Monoclonal Antibodies in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Monoclonal Antibodies manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Monoclonal Antibodies sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Monoclonal Antibodies Definition
1.2 Market by Type
1.2.1 Global Monoclonal Antibodies Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Erythropoietin (EPO)
1.2.3 Human Growth Hormone (HGH)
1.2.4 Granulocyte- Colony Stimulating Factor (G-CSF)
1.2.5 Monoclonal Antibody (mAb)
1.2.6 Insulin
1.2.7 Interferon (IFN)
1.2.8 Others
1.3 Market Segment by Application
1.3.1 Global Monoclonal Antibodies Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Anti-Cancer
1.3.3 Anti-Inflammatory/Autoimmune
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Monoclonal Antibodies Sales
2.1 Global Monoclonal Antibodies Revenue Estimates and Forecasts 2018-2034
2.2 Global Monoclonal Antibodies Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Monoclonal Antibodies Revenue by Region
2.3.1 Global Monoclonal Antibodies Revenue by Region (2018-2023)
2.3.2 Global Monoclonal Antibodies Revenue by Region (2024-2034)
2.4 Global Monoclonal Antibodies Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Monoclonal Antibodies Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Monoclonal Antibodies Sales Quantity by Region
2.6.1 Global Monoclonal Antibodies Sales Quantity by Region (2018-2023)
2.6.2 Global Monoclonal Antibodies Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Monoclonal Antibodies Sales Quantity by Manufacturers
3.1.1 Global Monoclonal Antibodies Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Monoclonal Antibodies Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Monoclonal Antibodies Sales in 2024
3.2 Global Monoclonal Antibodies Revenue by Manufacturers
3.2.1 Global Monoclonal Antibodies Revenue by Manufacturers (2018-2023)
3.2.2 Global Monoclonal Antibodies Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Monoclonal Antibodies Revenue in 2024
3.3 Global Monoclonal Antibodies Sales Price by Manufacturers
3.4 Global Key Players of Monoclonal Antibodies, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Monoclonal Antibodies, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Monoclonal Antibodies, Product Offered and Application
3.8 Global Key Manufacturers of Monoclonal Antibodies, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Monoclonal Antibodies Sales Quantity by Type
4.1.1 Global Monoclonal Antibodies Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Monoclonal Antibodies Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Monoclonal Antibodies Sales Quantity Market Share by Type (2018-2034)
4.2 Global Monoclonal Antibodies Revenue by Type
4.2.1 Global Monoclonal Antibodies Historical Revenue by Type (2018-2023)
4.2.2 Global Monoclonal Antibodies Forecasted Revenue by Type (2024-2034)
4.2.3 Global Monoclonal Antibodies Revenue Market Share by Type (2018-2034)
4.3 Global Monoclonal Antibodies Price by Type
4.3.1 Global Monoclonal Antibodies Price by Type (2018-2023)
4.3.2 Global Monoclonal Antibodies Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Monoclonal Antibodies Sales Quantity by Application
5.1.1 Global Monoclonal Antibodies Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Monoclonal Antibodies Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Monoclonal Antibodies Sales Quantity Market Share by Application (2018-2034)
5.2 Global Monoclonal Antibodies Revenue by Application
5.2.1 Global Monoclonal Antibodies Historical Revenue by Application (2018-2023)
5.2.2 Global Monoclonal Antibodies Forecasted Revenue by Application (2024-2034)
5.2.3 Global Monoclonal Antibodies Revenue Market Share by Application (2018-2034)
5.3 Global Monoclonal Antibodies Price by Application
5.3.1 Global Monoclonal Antibodies Price by Application (2018-2023)
5.3.2 Global Monoclonal Antibodies Price Forecast by Application (2024-2034)
6 North America
6.1 North America Monoclonal Antibodies Sales by Company
6.1.1 North America Monoclonal Antibodies Revenue by Company (2018-2023)
6.1.2 North America Monoclonal Antibodies Sales Quantity by Company (2018-2023)
6.2 North America Monoclonal Antibodies Market Size by Type
6.2.1 North America Monoclonal Antibodies Sales Quantity by Type (2018-2034)
6.2.2 North America Monoclonal Antibodies Revenue by Type (2018-2034)
6.3 North America Monoclonal Antibodies Market Size by Application
6.3.1 North America Monoclonal Antibodies Sales Quantity by Application (2018-2034)
6.3.2 North America Monoclonal Antibodies Revenue by Application (2018-2034)
6.4 North America Monoclonal Antibodies Market Size by Country
6.4.1 North America Monoclonal Antibodies Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Monoclonal Antibodies Revenue by Country (2018-2034)
6.4.3 North America Monoclonal Antibodies Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Monoclonal Antibodies Sales by Company
7.1.1 Europe Monoclonal Antibodies Sales Quantity by Company (2018-2023)
7.1.2 Europe Monoclonal Antibodies Revenue by Company (2018-2023)
7.2 Europe Monoclonal Antibodies Market Size by Type
7.2.1 Europe Monoclonal Antibodies Sales Quantity by Type (2018-2034)
7.2.2 Europe Monoclonal Antibodies Revenue by Type (2018-2034)
7.3 Europe Monoclonal Antibodies Market Size by Application
7.3.1 Europe Monoclonal Antibodies Sales Quantity by Application (2018-2034)
7.3.2 Europe Monoclonal Antibodies Revenue by Application (2018-2034)
7.4 Europe Monoclonal Antibodies Market Size by Country
7.4.1 Europe Monoclonal Antibodies Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Monoclonal Antibodies Revenue by Country (2018-2034)
7.4.3 Europe Monoclonal Antibodies Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Monoclonal Antibodies Sales by Company
8.1.1 China Monoclonal Antibodies Sales Quantity by Company (2018-2023)
8.1.2 China Monoclonal Antibodies Revenue by Company (2018-2023)
8.2 China Monoclonal Antibodies Market Size by Type
8.2.1 China Monoclonal Antibodies Sales Quantity by Type (2018-2034)
8.2.2 China Monoclonal Antibodies Revenue by Type (2018-2034)
8.3 China Monoclonal Antibodies Market Size by Application
8.3.1 China Monoclonal Antibodies Sales Quantity by Application (2018-2034)
8.3.2 China Monoclonal Antibodies Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Monoclonal Antibodies Sales by Company
9.1.1 APAC Monoclonal Antibodies Sales Quantity by Company (2018-2023)
9.1.2 APAC Monoclonal Antibodies Revenue by Company (2018-2023)
9.2 APAC Monoclonal Antibodies Market Size by Type
9.2.1 APAC Monoclonal Antibodies Sales Quantity by Type (2018-2034)
9.2.2 APAC Monoclonal Antibodies Revenue by Type (2018-2034)
9.3 APAC Monoclonal Antibodies Market Size by Application
9.3.1 APAC Monoclonal Antibodies Sales Quantity by Application (2018-2034)
9.3.2 APAC Monoclonal Antibodies Revenue by Application (2018-2034)
9.4 APAC Monoclonal Antibodies Market Size by Region
9.4.1 APAC Monoclonal Antibodies Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Monoclonal Antibodies Revenue by Region (2018-2034)
9.4.3 APAC Monoclonal Antibodies Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Monoclonal Antibodies Sales by Company
10.1.1 Middle East, Africa and Latin America Monoclonal Antibodies Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Monoclonal Antibodies Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Monoclonal Antibodies Market Size by Type
10.2.1 Middle East, Africa and Latin America Monoclonal Antibodies Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Monoclonal Antibodies Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Monoclonal Antibodies Market Size by Application
10.3.1 Middle East, Africa and Latin America Monoclonal Antibodies Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Monoclonal Antibodies Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Monoclonal Antibodies Market Size by Country
10.4.1 Middle East, Africa and Latin America Monoclonal Antibodies Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Monoclonal Antibodies Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Monoclonal Antibodies Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Biocon
11.1.1 Biocon Company Information
11.1.2 Biocon Overview
11.1.3 Biocon Monoclonal Antibodies Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Biocon Monoclonal Antibodies Products and Services
11.1.5 Biocon Monoclonal Antibodies SWOT Analysis
11.1.6 Biocon Recent Developments
11.2 Celltrion
11.2.1 Celltrion Company Information
11.2.2 Celltrion Overview
11.2.3 Celltrion Monoclonal Antibodies Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Celltrion Monoclonal Antibodies Products and Services
11.2.5 Celltrion Monoclonal Antibodies SWOT Analysis
11.2.6 Celltrion Recent Developments
11.3 Dr. Reddy's Laboratories
11.3.1 Dr. Reddy's Laboratories Company Information
11.3.2 Dr. Reddy's Laboratories Overview
11.3.3 Dr. Reddy's Laboratories Monoclonal Antibodies Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Dr. Reddy's Laboratories Monoclonal Antibodies Products and Services
11.3.5 Dr. Reddy's Laboratories Monoclonal Antibodies SWOT Analysis
11.3.6 Dr. Reddy's Laboratories Recent Developments
11.4 Hospira
11.4.1 Hospira Company Information
11.4.2 Hospira Overview
11.4.3 Hospira Monoclonal Antibodies Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Hospira Monoclonal Antibodies Products and Services
11.4.5 Hospira Monoclonal Antibodies SWOT Analysis
11.4.6 Hospira Recent Developments
11.5 3SBio
11.5.1 3SBio Company Information
11.5.2 3SBio Overview
11.5.3 3SBio Monoclonal Antibodies Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 3SBio Monoclonal Antibodies Products and Services
11.5.5 3SBio Monoclonal Antibodies SWOT Analysis
11.5.6 3SBio Recent Developments
11.6 Accord Healthcare
11.6.1 Accord Healthcare Company Information
11.6.2 Accord Healthcare Overview
11.6.3 Accord Healthcare Monoclonal Antibodies Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Accord Healthcare Monoclonal Antibodies Products and Services
11.6.5 Accord Healthcare Monoclonal Antibodies SWOT Analysis
11.6.6 Accord Healthcare Recent Developments
11.7 AET Biotech
11.7.1 AET Biotech Company Information
11.7.2 AET Biotech Overview
11.7.3 AET Biotech Monoclonal Antibodies Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 AET Biotech Monoclonal Antibodies Products and Services
11.7.5 AET Biotech Monoclonal Antibodies SWOT Analysis
11.7.6 AET Biotech Recent Developments
11.8 Allergan
11.8.1 Allergan Company Information
11.8.2 Allergan Overview
11.8.3 Allergan Monoclonal Antibodies Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Allergan Monoclonal Antibodies Products and Services
11.8.5 Allergan Monoclonal Antibodies SWOT Analysis
11.8.6 Allergan Recent Developments
11.9 Amega Biotech
11.9.1 Amega Biotech Company Information
11.9.2 Amega Biotech Overview
11.9.3 Amega Biotech Monoclonal Antibodies Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Amega Biotech Monoclonal Antibodies Products and Services
11.9.5 Amega Biotech Monoclonal Antibodies SWOT Analysis
11.9.6 Amega Biotech Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Monoclonal Antibodies Value Chain Analysis
12.2 Monoclonal Antibodies Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Monoclonal Antibodies Production Mode & Process
12.4 Monoclonal Antibodies Sales and Marketing
12.4.1 Monoclonal Antibodies Sales Channels
12.4.2 Monoclonal Antibodies Distributors
12.5 Monoclonal Antibodies Customers
13 Market Dynamics
13.1 Monoclonal Antibodies Industry Trends
13.2 Monoclonal Antibodies Market Drivers
13.3 Monoclonal Antibodies Market Challenges
13.4 Monoclonal Antibodies Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Monoclonal Antibodies Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Erythropoietin (EPO)
Table 3. Major Manufacturers of Human Growth Hormone (HGH)
Table 4. Major Manufacturers of Granulocyte- Colony Stimulating Factor (G-CSF)
Table 5. Major Manufacturers of Monoclonal Antibody (mAb)
Table 6. Major Manufacturers of Insulin
Table 7. Major Manufacturers of Interferon (IFN)
Table 8. Major Manufacturers of Others
Table 9. Global Monoclonal Antibodies Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Monoclonal Antibodies Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 11. Global Monoclonal Antibodies Revenue by Region (2018-2023) & (US$ Million)
Table 12. Global Monoclonal Antibodies Revenue Market Share by Region (2018-2023)
Table 13. Global Monoclonal Antibodies Revenue by Region (2024-2034) & (US$ Million)
Table 14. Global Monoclonal Antibodies Revenue Market Share by Region (2024-2034)
Table 15. Global Monoclonal Antibodies Sales Quantity by Region: 2018 VS 2024 VS 2034 (Units)
Table 16. Global Monoclonal Antibodies Sales by Region (2018-2023) & (Units)
Table 17. Global Monoclonal Antibodies Sales Market Share by Region (2018-2023)
Table 18. Global Monoclonal Antibodies Sales by Region (2024-2034) & (Units)
Table 19. Global Monoclonal Antibodies Sales Market Share by Region (2024-2034)
Table 20. Global Monoclonal Antibodies Sales Quantity by Manufacturers (2018-2023) & (Units)
Table 21. Global Monoclonal Antibodies Sales Quantity Share by Manufacturers (2018-2023)
Table 22. Global Monoclonal Antibodies Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 23. Global Monoclonal Antibodies Revenue Share by Manufacturers (2018-2023)
Table 24. Global Monoclonal Antibodies Price by Manufacturers 2018-2023 (USD/Unit)
Table 25. Global Key Players of Monoclonal Antibodies, Industry Ranking, 2021 VS 2024
Table 26. Global Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Monoclonal Antibodies by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibodies as of 2024)
Table 28. Global Key Manufacturers of Monoclonal Antibodies, Manufacturing Base Distribution and Headquarters
Table 29. Global Key Manufacturers of Monoclonal Antibodies, Product Offered and Application
Table 30. Global Key Manufacturers of Monoclonal Antibodies, Date of Enter into This Industry
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Monoclonal Antibodies Sales Quantity by Type (2018-2023) & (Units)
Table 33. Global Monoclonal Antibodies Sales Quantity by Type (2024-2034) & (Units)
Table 34. Global Monoclonal Antibodies Sales Quantity Share by Type (2018-2023)
Table 35. Global Monoclonal Antibodies Sales Quantity Share by Type (2024-2034)
Table 36. Global Monoclonal Antibodies Revenue by Type (2018-2023) & (US$ Million)
Table 37. Global Monoclonal Antibodies Revenue by Type (2024-2034) & (US$ Million)
Table 38. Global Monoclonal Antibodies Revenue Share by Type (2018-2023)
Table 39. Global Monoclonal Antibodies Revenue Share by Type (2024-2034)
Table 40. Monoclonal Antibodies Price by Type (2018-2023) & (USD/Unit)
Table 41. Global Monoclonal Antibodies Price Forecast by Type (2024-2034) & (USD/Unit)
Table 42. Global Monoclonal Antibodies Sales Quantity by Application (2018-2023) & (Units)
Table 43. Global Monoclonal Antibodies Sales Quantity by Application (2024-2034) & (Units)
Table 44. Global Monoclonal Antibodies Sales Quantity Share by Application (2018-2023)
Table 45. Global Monoclonal Antibodies Sales Quantity Share by Application (2024-2034)
Table 46. Global Monoclonal Antibodies Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global Monoclonal Antibodies Revenue by Application (2024-2034) & (US$ Million)
Table 48. Global Monoclonal Antibodies Revenue Share by Application (2018-2023)
Table 49. Global Monoclonal Antibodies Revenue Share by Application (2024-2034)
Table 50. Monoclonal Antibodies Price by Application (2018-2023) & (USD/Unit)
Table 51. Global Monoclonal Antibodies Price Forecast by Application (2024-2034) & (USD/Unit)
Table 52. North America Monoclonal Antibodies Revenue by Company (2018-2023) & (US$ Million)
Table 53. North America Monoclonal Antibodies Sales Quantity by Company (2018-2023) & (Units)
Table 54. North America Monoclonal Antibodies Sales Quantity by Type (2018-2023) & (Units)
Table 55. North America Monoclonal Antibodies Sales Quantity by Type (2024-2034) & (Units)
Table 56. North America Monoclonal Antibodies Revenue by Type (2018-2023) & (US$ Million)
Table 57. North America Monoclonal Antibodies Revenue by Type (2024-2034) & (US$ Million)
Table 58. North America Monoclonal Antibodies Sales Quantity by Application (2018-2023) & (Units)
Table 59. North America Monoclonal Antibodies Sales Quantity by Application (2024-2034) & (Units)
Table 60. North America Monoclonal Antibodies Revenue by Application (2018-2023) & (US$ Million)
Table 61. North America Monoclonal Antibodies Revenue by Application (2024-2034) & (US$ Million)
Table 62. North America Monoclonal Antibodies Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 63. North America Monoclonal Antibodies Revenue by Country (2018-2023) & (US$ Million)
Table 64. North America Monoclonal Antibodies Revenue by Country (2024-2034) & (US$ Million)
Table 65. North America Monoclonal Antibodies Sales Quantity by Country (2018-2023) & (Units)
Table 66. North America Monoclonal Antibodies Sales Quantity by Country (2024-2034) & (Units)
Table 67. Europe Monoclonal Antibodies Sales Quantity by Company (2018-2023) & (Units)
Table 68. Europe Monoclonal Antibodies Revenue by Company (2018-2023) & (US$ Million)
Table 69. Europe Monoclonal Antibodies Sales Quantity by Type (2018-2023) & (Units)
Table 70. Europe Monoclonal Antibodies Sales Quantity by Type (2024-2034) & (Units)
Table 71. Europe Monoclonal Antibodies Revenue by Type (2018-2023) & (US$ Million)
Table 72. Europe Monoclonal Antibodies Revenue by Type (2024-2034) & (US$ Million)
Table 73. Europe Monoclonal Antibodies Sales Quantity by Application (2018-2023) & (Units)
Table 74. Europe Monoclonal Antibodies Sales Quantity by Application (2024-2034) & (Units)
Table 75. Europe Monoclonal Antibodies Revenue by Application (2018-2023) & (US$ Million)
Table 76. Europe Monoclonal Antibodies Revenue by Application (2024-2034) & (US$ Million)
Table 77. Europe Monoclonal Antibodies Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 78. Europe Monoclonal Antibodies Revenue by Country (2018-2023) & (US$ Million)
Table 79. Europe Monoclonal Antibodies Revenue by Country (2024-2034) & (US$ Million)
Table 80. Europe Monoclonal Antibodies Sales Quantity by Country (2018-2023) & (Units)
Table 81. Europe Monoclonal Antibodies Sales Quantity by Country (2024-2034) & (Units)
Table 82. China Monoclonal Antibodies Sales Quantity by Company (2018-2023) & (Units)
Table 83. China Monoclonal Antibodies Revenue by Company (2018-2023) & (US$ Million)
Table 84. China Monoclonal Antibodies Sales Quantity by Type (2018-2023) & (Units)
Table 85. China Monoclonal Antibodies Sales Quantity by Type (2024-2034) & (Units)
Table 86. China Monoclonal Antibodies Revenue by Type (2018-2023) & (US$ Million)
Table 87. China Monoclonal Antibodies Revenue by Type (2024-2034) & (US$ Million)
Table 88. China Monoclonal Antibodies Sales Quantity by Application (2018-2023) & (Units)
Table 89. China Monoclonal Antibodies Sales Quantity by Application (2024-2034) & (Units)
Table 90. China Monoclonal Antibodies Revenue by Application (2018-2023) & (US$ Million)
Table 91. China Monoclonal Antibodies Revenue by Application (2024-2034) & (US$ Million)
Table 92. APAC Monoclonal Antibodies Sales Quantity by Company (2018-2023) & (Units)
Table 93. APAC Monoclonal Antibodies Revenue by Company (2018-2023) & (US$ Million)
Table 94. APAC Monoclonal Antibodies Sales Quantity by Type (2018-2023) & (Units)
Table 95. APAC Monoclonal Antibodies Sales Quantity by Type (2024-2034) & (Units)
Table 96. APAC Monoclonal Antibodies Revenue by Type (2018-2023) & (US$ Million)
Table 97. APAC Monoclonal Antibodies Revenue by Type (2024-2034) & (US$ Million)
Table 98. APAC Monoclonal Antibodies Sales Quantity by Application (2018-2023) & (Units)
Table 99. APAC Monoclonal Antibodies Sales Quantity by Application (2024-2034) & (Units)
Table 100. APAC Monoclonal Antibodies Revenue by Application (2018-2023) & (US$ Million)
Table 101. APAC Monoclonal Antibodies Revenue by Application (2024-2034) & (US$ Million)
Table 102. APAC Monoclonal Antibodies Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 103. APAC Monoclonal Antibodies Revenue by Region (2018-2023) & (US$ Million)
Table 104. APAC Monoclonal Antibodies Revenue by Region (2024-2034) & (US$ Million)
Table 105. APAC Monoclonal Antibodies Sales Quantity by Region (2018-2023) & (Units)
Table 106. APAC Monoclonal Antibodies Sales Quantity by Region (2024-2034) & (Units)
Table 107. Middle East, Africa and Latin America Monoclonal Antibodies Sales Quantity by Company (2018-2023) & (Units)
Table 108. Middle East, Africa and Latin America Monoclonal Antibodies Revenue by Company (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America Monoclonal Antibodies Sales Quantity by Type (2018-2023) & (Units)
Table 110. Middle East, Africa and Latin America Monoclonal Antibodies Sales Quantity by Type (2024-2034) & (Units)
Table 111. Middle East, Africa and Latin America Monoclonal Antibodies Revenue by Type (2018-2023) & (US$ Million)
Table 112. Middle East, Africa and Latin America Monoclonal Antibodies Revenue by Type (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America Monoclonal Antibodies Sales Quantity by Application (2018-2023) & (Units)
Table 114. Middle East, Africa and Latin America Monoclonal Antibodies Sales Quantity by Application (2024-2034) & (Units)
Table 115. Middle East, Africa and Latin America Monoclonal Antibodies Revenue by Application (2018-2023) & (US$ Million)
Table 116. Middle East, Africa and Latin America Monoclonal Antibodies Revenue by Application (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Monoclonal Antibodies Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 118. Middle East, Africa and Latin America Monoclonal Antibodies Revenue by Country (2018-2023) & (US$ Million)
Table 119. Middle East, Africa and Latin America Monoclonal Antibodies Revenue by Country (2024-2034) & (US$ Million)
Table 120. Middle East, Africa and Latin America Monoclonal Antibodies Sales Quantity by Country (2018-2023) & (Units)
Table 121. Middle East, Africa and Latin America Monoclonal Antibodies Sales Quantity by Country (2024-2034) & (Units)
Table 122. Biocon Company Information
Table 123. Biocon Description and Overview
Table 124. Biocon Monoclonal Antibodies Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 125. Biocon Monoclonal Antibodies Product and Services
Table 126. Biocon Monoclonal Antibodies SWOT Analysis
Table 127. Biocon Recent Developments
Table 128. Celltrion Company Information
Table 129. Celltrion Description and Overview
Table 130. Celltrion Monoclonal Antibodies Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 131. Celltrion Monoclonal Antibodies Product and Services
Table 132. Celltrion Monoclonal Antibodies SWOT Analysis
Table 133. Celltrion Recent Developments
Table 134. Dr. Reddy's Laboratories Company Information
Table 135. Dr. Reddy's Laboratories Description and Overview
Table 136. Dr. Reddy's Laboratories Monoclonal Antibodies Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 137. Dr. Reddy's Laboratories Monoclonal Antibodies Product and Services
Table 138. Dr. Reddy's Laboratories Monoclonal Antibodies SWOT Analysis
Table 139. Dr. Reddy's Laboratories Recent Developments
Table 140. Hospira Company Information
Table 141. Hospira Description and Overview
Table 142. Hospira Monoclonal Antibodies Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 143. Hospira Monoclonal Antibodies Product and Services
Table 144. Hospira Monoclonal Antibodies SWOT Analysis
Table 145. Hospira Recent Developments
Table 146. 3SBio Company Information
Table 147. 3SBio Description and Overview
Table 148. 3SBio Monoclonal Antibodies Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 149. 3SBio Monoclonal Antibodies Product and Services
Table 150. 3SBio Monoclonal Antibodies SWOT Analysis
Table 151. 3SBio Recent Developments
Table 152. Accord Healthcare Company Information
Table 153. Accord Healthcare Description and Overview
Table 154. Accord Healthcare Monoclonal Antibodies Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 155. Accord Healthcare Monoclonal Antibodies Product and Services
Table 156. Accord Healthcare Monoclonal Antibodies SWOT Analysis
Table 157. Accord Healthcare Recent Developments
Table 158. AET Biotech Company Information
Table 159. AET Biotech Description and Overview
Table 160. AET Biotech Monoclonal Antibodies Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 161. AET Biotech Monoclonal Antibodies Product and Services
Table 162. AET Biotech Monoclonal Antibodies SWOT Analysis
Table 163. AET Biotech Recent Developments
Table 164. Allergan Company Information
Table 165. Allergan Description and Overview
Table 166. Allergan Monoclonal Antibodies Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 167. Allergan Monoclonal Antibodies Product and Services
Table 168. Allergan Monoclonal Antibodies SWOT Analysis
Table 169. Allergan Recent Developments
Table 170. Amega Biotech Company Information
Table 171. Amega Biotech Description and Overview
Table 172. Amega Biotech Monoclonal Antibodies Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 173. Amega Biotech Monoclonal Antibodies Product and Services
Table 174. Amega Biotech Monoclonal Antibodies SWOT Analysis
Table 175. Amega Biotech Recent Developments
Table 176. Key Raw Materials Lists
Table 177. Raw Materials Key Suppliers Lists
Table 178. Monoclonal Antibodies Distributors List
Table 179. Monoclonal Antibodies Customers List
Table 180. Monoclonal Antibodies Market Trends
Table 181. Monoclonal Antibodies Market Drivers
Table 182. Monoclonal Antibodies Market Challenges
Table 183. Monoclonal Antibodies Market Restraints
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Monoclonal Antibodies Product Picture
Figure 2. Global Monoclonal Antibodies Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Monoclonal Antibodies Market Share by Type in 2024 & 2034
Figure 4. Erythropoietin (EPO) Product Picture
Figure 5. Human Growth Hormone (HGH) Product Picture
Figure 6. Granulocyte- Colony Stimulating Factor (G-CSF) Product Picture
Figure 7. Monoclonal Antibody (mAb) Product Picture
Figure 8. Insulin Product Picture
Figure 9. Interferon (IFN) Product Picture
Figure 10. Others Product Picture
Figure 11. Global Monoclonal Antibodies Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 12. Global Monoclonal Antibodies Market Share by Application in 2024 & 2034
Figure 13. Anti-Cancer
Figure 14. Anti-Inflammatory/Autoimmune
Figure 15. Monoclonal Antibodies Report Years Considered
Figure 16. Global Monoclonal Antibodies Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 17. Global Monoclonal Antibodies Revenue 2018-2034 (US$ Million)
Figure 18. Global Monoclonal Antibodies Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 19. Global Monoclonal Antibodies Sales Quantity 2018-2034 (Units)
Figure 20. Global Monoclonal Antibodies Sales Quantity Market Share by Region (2018-2023)
Figure 21. Global Monoclonal Antibodies Sales Quantity Market Share by Region (2024-2034)
Figure 22. North America Monoclonal Antibodies Sales Quantity YoY (2018-2034) & (Units)
Figure 23. North America Monoclonal Antibodies Revenue YoY (2018-2034) & (US$ Million)
Figure 24. Europe Monoclonal Antibodies Sales Quantity YoY (2018-2034) & (Units)
Figure 25. Europe Monoclonal Antibodies Revenue YoY (2018-2034) & (US$ Million)
Figure 26. China Monoclonal Antibodies Sales Quantity YoY (2018-2034) & (Units)
Figure 27. China Monoclonal Antibodies Revenue YoY (2018-2034) & (US$ Million)
Figure 28. APAC Monoclonal Antibodies Sales Quantity YoY (2018-2034) & (Units)
Figure 29. APAC Monoclonal Antibodies Revenue YoY (2018-2034) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Monoclonal Antibodies Sales Quantity YoY (2018-2034) & (Units)
Figure 31. Middle East, Africa and Latin America Monoclonal Antibodies Revenue YoY (2018-2034) & (US$ Million)
Figure 32. The Top 10 and Top 5 Players Market Share by Monoclonal Antibodies Sales Quantity in 2024
Figure 33. The Top 10 and Top 5 Players Market Share by Monoclonal Antibodies Revenue in 2024
Figure 34. Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 35. Global Monoclonal Antibodies Sales Quantity Market Share by Type (2018-2034)
Figure 36. Global Monoclonal Antibodies Revenue Market Share by Type (2018-2034)
Figure 37. Global Monoclonal Antibodies Sales Quantity Market Share by Application (2018-2034)
Figure 38. Global Monoclonal Antibodies Revenue Market Share by Application (2018-2034)
Figure 39. North America Monoclonal Antibodies Revenue Market Share by Company in 2024
Figure 40. North America Monoclonal Antibodies Sales Quantity Market Share by Company in 2024
Figure 41. North America Monoclonal Antibodies Sales Quantity Market Share by Type (2018-2034)
Figure 42. North America Monoclonal Antibodies Revenue Market Share by Type (2018-2034)
Figure 43. North America Monoclonal Antibodies Sales Quantity Market Share by Application (2018-2034)
Figure 44. North America Monoclonal Antibodies Revenue Market Share by Application (2018-2034)
Figure 45. North America Monoclonal Antibodies Revenue Share by Country (2018-2034)
Figure 46. North America Monoclonal Antibodies Sales Quantity Share by Country (2018-2034)
Figure 47. U.S. Monoclonal Antibodies Revenue (2018-2034) & (US$ Million)
Figure 48. Canada Monoclonal Antibodies Revenue (2018-2034) & (US$ Million)
Figure 49. Europe Monoclonal Antibodies Sales Quantity Market Share by Company in 2024
Figure 50. Europe Monoclonal Antibodies Revenue Market Share by Company in 2024
Figure 51. Europe Monoclonal Antibodies Sales Quantity Market Share by Type (2018-2034)
Figure 52. Europe Monoclonal Antibodies Revenue Market Share by Type (2018-2034)
Figure 53. Europe Monoclonal Antibodies Sales Quantity Market Share by Application (2018-2034)
Figure 54. Europe Monoclonal Antibodies Revenue Market Share by Application (2018-2034)
Figure 55. Europe Monoclonal Antibodies Revenue Share by Country (2018-2034)
Figure 56. Europe Monoclonal Antibodies Sales Quantity Share by Country (2018-2034)
Figure 57. Germany Monoclonal Antibodies Revenue (2018-2034) & (US$ Million)
Figure 58. France Monoclonal Antibodies Revenue (2018-2034) & (US$ Million)
Figure 59. U.K. Monoclonal Antibodies Revenue (2018-2034) & (US$ Million)
Figure 60. Italy Monoclonal Antibodies Revenue (2018-2034) & (US$ Million)
Figure 61. Russia Monoclonal Antibodies Revenue (2018-2034) & (US$ Million)
Figure 62. China Monoclonal Antibodies Sales Quantity Market Share by Company in 2024
Figure 63. China Monoclonal Antibodies Revenue Market Share by Company in 2024
Figure 64. China Monoclonal Antibodies Sales Quantity Market Share by Type (2018-2034)
Figure 65. China Monoclonal Antibodies Revenue Market Share by Type (2018-2034)
Figure 66. China Monoclonal Antibodies Sales Quantity Market Share by Application (2018-2034)
Figure 67. China Monoclonal Antibodies Revenue Market Share by Application (2018-2034)
Figure 68. APAC Monoclonal Antibodies Sales Quantity Market Share by Company in 2024
Figure 69. APAC Monoclonal Antibodies Revenue Market Share by Company in 2024
Figure 70. APAC Monoclonal Antibodies Sales Quantity Market Share by Type (2018-2034)
Figure 71. APAC Monoclonal Antibodies Revenue Market Share by Type (2018-2034)
Figure 72. APAC Monoclonal Antibodies Sales Quantity Market Share by Application (2018-2034)
Figure 73. APAC Monoclonal Antibodies Revenue Market Share by Application (2018-2034)
Figure 74. APAC Monoclonal Antibodies Revenue Share by Region (2018-2034)
Figure 75. APAC Monoclonal Antibodies Sales Quantity Share by Region (2018-2034)
Figure 76. Japan Monoclonal Antibodies Revenue (2018-2034) & (US$ Million)
Figure 77. South Korea Monoclonal Antibodies Revenue (2018-2034) & (US$ Million)
Figure 78. China Taiwan Monoclonal Antibodies Revenue (2018-2034) & (US$ Million)
Figure 79. Southeast Asia Monoclonal Antibodies Revenue (2018-2034) & (US$ Million)
Figure 80. India Monoclonal Antibodies Revenue (2018-2034) & (US$ Million)
Figure 81. Middle East, Africa and Latin America Monoclonal Antibodies Sales Quantity Market Share by Company in 2024
Figure 82. Middle East, Africa and Latin America Monoclonal Antibodies Revenue Market Share by Company in 2024
Figure 83. Middle East, Africa and Latin America Monoclonal Antibodies Sales Quantity Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Monoclonal Antibodies Revenue Market Share by Type (2018-2034)
Figure 85. Middle East, Africa and Latin America Monoclonal Antibodies Sales Quantity Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Monoclonal Antibodies Revenue Market Share by Application (2018-2034)
Figure 87. Middle East, Africa and Latin America Monoclonal Antibodies Sales Quantity Share by Country (2018-2034)
Figure 88. Middle East, Africa and Latin America Monoclonal Antibodies Revenue Share by Country (2018-2034)
Figure 89. Brazil Monoclonal Antibodies Revenue (2018-2034) & (US$ Million)
Figure 90. Mexico Monoclonal Antibodies Revenue (2018-2034) & (US$ Million)
Figure 91. Turkey Monoclonal Antibodies Revenue (2018-2034) & (US$ Million)
Figure 92. Israel Monoclonal Antibodies Revenue (2018-2034) & (US$ Million)
Figure 93. GCC Countries Monoclonal Antibodies Revenue (2018-2034) & (US$ Million)
Figure 94. Monoclonal Antibodies Value Chain
Figure 95. Monoclonal Antibodies Production Process
Figure 96. Channels of Distribution (Direct Vs Distribution)
Figure 97. Distributors Profiles
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries